Background: Stimulants are used increasingly to enhance social (cocaine) or cognitive performance (stimulants normally prescribed, prescription stimulants [e.g., methylphenidate, amphetamines]). Chronic use, by contrast, has been associated with significant verbal memory and learning deficits. This study sought to determine whether subtle learning and memory problems characterize individuals who exhibit occasional but not chronic use of stimulants.
P sychostimulants such as methylphenidate and amphetamine (prescription stimulants) have become drugs of choice for the treatment of attention-deficit/hyperactivity disorder (1) . Given the increasing availability of recreational stimulants like powder cocaine, prescription medications and illegal drugs together contribute to the increasing rates of stimulants being abused, particularly by young adults. An estimated half-million Americans consume cocaine weekly, and approximately 98,000 adolescents would meet criteria for stimulant abuse or dependence (2) . The incentives for stimulant abuse are multifactorial; one of the frequently reported motivations is to improve "performance" (i.e., to do better on tests [prescription stimulants] or to feel more comfortable in social situations [cocaine] ). In line with those self-reports, 7%-8% of college students reported to have used prescription stimulants in the past year (3, 4) , and approximately 17% of male and 11% of female undergraduates reported lifetime use of prescription stimulants (5) . It is unclear, however, whether nondependent users of such drugs show neurocognitive deficits and in particular whether deficits precede the use of stimulants.
In comparison, the chronic use of psychostimulants has been associated with neurocognitive deficits, such as verbal learning and memory deficits in cocaine users (6 -12) , which are not explained by insufficient attentional and working memory capacities (7, 10) . On verbal learning and memory tests like the California Verbal Learning Test (CVLT-II) (13) , cocaine-dependent subjects showed impaired word recall, learning, and recognition performance (7, 10) and increased intrusion and repetition error rates (7) . These deficits are also measurable during abstinence and withdrawal (11, 12, 14, 15) , and cumulative cocaine use was shown to negatively impact learning and memory performance (8, 16) . Visuospatial learning and recall performance, by contrast, was increased in cocaine users (6, 15) , supporting the view of a specific verbal learning and memory impairment. Others, however, have not been able to replicate verbal memory and learning weaknesses in cocaine users (17, 18) , a fact that might be related to small effect sizes and sample sizes drawn on as meta-analyses and effect size analyses (19) on cocaine use reveal that higher effect sizes were achieved for tests on attentional capacities. Moreover, differential working memory capacities in users and comparison subjects, which were shown to be of above-median effect size (19) , might account for some of the discrepancies. The effect of prescription stimulants on learning and memory has mainly been investigated in administration studies in stimulant-naive subjects, where a positive effect of amphetamine on novel word-learning (20, 21) and on the retention of verbal material has been described (22) (23) (24) .
The identification of neurocognitive deficits in very early stages of stimulant use, thus in users who have used these drugs only rarely, could provide evidence that these deficiencies preceded the use of such drugs. Moreover, such deficits might act as an incentive to initiate use and thus serve as a vulnerability marker for stimulant use and dependence. Nevertheless, such studies are rare. Here, we assessed verbal learning and memory in occasional young (age 18 -25) users of cocaine and/or pre-scription stimulants (amphetamine, methylphenidate)-users who only recently started using psychostimulants and who have not developed problems with stimulant use-to identify potential learning and memory deficits.
The off-prescription use of normally prescribed stimulants is associated with lower grade point averages (4) , and longitudinal analyses of children at high risk of substance use report that deficits in "neurobehavioral inhibition" at age 16 predicted substance use disorders at age 19 with an 85% accuracy (25, 26) and thus point toward a pre-existing neuropsychological deficiency. Additionally, higher rates of cocaine use were negatively associated with verbal memory (10) and learning (12) , suggesting progressive deficits with use. Taken together, the scarce literature suggests that some deficiencies might precede stimulant initiation and that verbal memory and learning is differentially affected by cumulative use of prescription stimulants and cocaine. We hypothesized occasional users of cocaine and prescription stimulants would show weaknesses of recall, learning, and recognition capacities and increased error rates (6, 7, 10, 15) . Acknowledging the cumulative effect of cocaine, we hypothesized deficits to be subtle compared with chronic users. Lastly, differential effects of cocaine and prescription stimulants were anticipated, with cumulative use of cocaine being associated with increased deficits. We hypothesized, on the basis of prior studies with prescription stimulants, two complementary scenarios: 1) if verbal capacities of users had been comparable to comparison subjects before use initiation, users of prescription stimulants would show improved verbal skills compared with stimulant-naive subjects; and 2) if there were initial deficiencies in verbal capacities before stimulant use, we hypothesized that stimulant use might attenuate these deficiencies.
The use of cannabinoids (⌬ 9 tetrahydrocannabinol, THC) is a major confound when examining neurocognitive functioning in stimulant users, because almost all individuals who report use of stimulants also admit to using THC. An estimated 76% of America's 14.8 million drug users used marijuana either alone (59%) or in conjunction with other drugs (17%), and college students reporting the abuse of prescription stimulants were 10 times as likely to report marijuana use than students not using stimulants (4) . Cannabis abusers have shown impaired performance on a variety of cognitive tasks (27) , with deficits being attributed to duration and frequency of use and performance deteriorating with increasing years of heavy frequent use (28) . To address a potential influence of marijuana on verbal performance of stimulant users, we classified stimulant users into low and high marijuana users (see data analysis for details).
Methods and Materials

Sample Description
The study protocol was approved by the local Human Subjects Review Board and was carried out in accordance with the Declaration of Helsinki. Stimulant users were recruited via flyers mailed to Ͼ7000 students at local universities, Internet advertisements, and local university newspapers. One thousand twenty-five stimulant users underwent intensive phone screens. One hundred fifty-four nondependent users of cocaine, prescription amphetamines, and/or methylphenidate and 48 comparison subjects were included into the study. Participants were informed that this study was aimed to examine behavior and brain functioning of people who use stimulants occasionally, and all subjects gave written informed consent. Subjects were between the ages 18 and 25 years. Inclusion criteria for comparison subjects were: 1) no lifetime use of stimulants, and 2) no lifetime history of substance-or alcohol-related problems. Stimulant users were defined as: 1) at least three off-prescription uses of cocaine and/or prescription stimulants (amphetamines/methylphenidate) over the past 6 months; 2) no evidence for lifetime stimulant dependence; and 3) never sought treatment of drugrelated problems. Subjects were assessed by experienced interviewers with the Semi Structured Assessment for the Genetics of Alcoholism (29) , and diagnoses were based on consensus meetings with a board-certified psychiatrist (M.P.P.) and trained study personnel. Five subjects met abuse criteria when participating in the study. The following were exclusion criteria for both groups: 1) evidence of attention-deficit/hyperactivity disorder; 2) use of stimulants for medical reasons; 3) lifetime use of ecstasy Ͼ20; 4) evidence for current (and past 6 months) of the following diagnoses: panic disorder, social phobia, post-traumatic stress disorder, major depressive disorder; 5) evidence of lifetime bipolar disorder, schizophrenia, or other cognitive disorders, or obsessive/compulsive disorder; 6) evidence of antisocial personality disorder; 7) positive urine toxicology test (exception: marijuana); and 8) head injuries or loss of consciousness Ͼ5 min. Twenty-one stimulant users reported previous use of methamphetamine; 15 of these had taken methamphetamine Ͻ10 times. For use of nicotine and alcohol, please refer to Supplement 1.
Task Description
Verbal learning and memory capacities were tested with the CVLT-II (13), where subjects are required to learn a list of 16 words (List A) over repeated immediate-recall trials before a distracting list (List B) is given. Short-and long-delayed recall tasks are administered in free and cued conditions, and yes/no recognition testing further allows for an assessment of components of verbal memory. Unbeknown to the subjects, both word lists are composed of four words of four semantic categories. The distracting second list contains two of the four semantic categories as the first, whereas the other categories are semantically unrelated. On all trials, responses are recorded verbatim, and no feedback is provided on the subject's performance.
At the onset of CVLT-II testing, List A is presented orally for immediate recall. The word list is read aloud at a pace slightly longer than 1 sec/word, and the subject is prompted to recall all the words in any order (Immediate Free Recall). Responses, including intrusions and repetitions, are recorded until the subject cannot remember more or has listed 20 words. List A is presented and recalled five times before List B is presented for one immediate recall trial. In the following trial, subjects recall List A without hearing it again (Short-Delay Free Recall). For the subsequent Short-Delay Cued Recall, the four categories of List A are provided, and the subject recalls corresponding words. A 20-min delay is required before long-delay testing continues (unknown to the subject). After the delay, the subject is instructed to recall List A (Long-Delay Free Recall). A yes/no recognition task follows directly afterward as 48 words (16 target words from List A, 16 distractor words from List B, and 16 phonologically or semantically related to List A) are read one at a time and the subject states whether a presented word was part of List A (Long-Delay Cued Recall). After another 10-min delay, 32 words are presented in pairs, and the subject identifies words belonging to List A (Long-Delay Forced-Choice Recognition). Each pair contains a target word from List A with a new distractor word.
Data Analysis
Performance data were entered into the program for the analysis of CVLT-II data, also scoring the data. To investigate whether stimulant users and comparison subjects differed on verbal recall capacities, scores on immediate recall measures (correct responses for List A Trial 1, Trial 5, Trials 1-5, and List B) and delayed recall measures (correct responses for Short-Delay Free Recall, Short-Delay Cued Recall, Long-Delay Free Recall, and Long-Delay Cued Recall) for List A were analyzed. Performance on immediate recall measures relies heavily on auditory attention span, whereas short-and long-delay recall measures assess the subject's ability to retrieve information from short-term memory storage after a time delay and exposure to an interference list. Regarding recognition capacities: False Positives and Total Recognition Discriminability Index deriving from the yes/no recognition task were calculated with Total Recognition Discriminability Index representing the ability to correctly identify all 16 target words while rejecting the 32 distractors, providing a score for correct responses relative to false positives. To assess effective encoding and retrieving of the word lists, the following scores were obtained: Semantic Clustering, the process by which subjects actively reorganize the words into their respective categorical groups; Serial Clustering Bidirectional, a "stimulus-bound", less-effective strategy of recalling target words in the same sequential forward or backward direction that they were presented; Learning Slope Trials 1-5, which determines the degree to which subjects learned more words in each successive immediate-recall trial of List A; and Recall Discriminability, which assesses the ability to cite target words relative to the number of intrusion errors. To reveal problems in learning and memory, recall error measures including the sum of repetition errors (words repeated during the same trial) across all recall trials (Total Repetitions) and intrusion errors (nontarget words) reported during immediate recall of List A Trials 1-5 (Immediate Intrusions), short-and long-delay recall trials (Delayed Recall Intrusions), and short-and long-delay cued recall trials (Cued Recall Intrusions) were analyzed.
Performance data were analyzed with SPSS (SPSS, Chicago, Illinois). Kolmogorov-Smirnov tests were carried out to test whether CVLT-II performance data in stimulant users and comparison subjects followed a normal distribution. Only 3 of the 18 variables were normally distributed, and variances between groups were inhomogeneous for 5 variables as tested with Levene's tests. Hence, assumptions for parametric analyses were not fulfilled, and we performed nonparametric Kruskal-Wallis tests to compare performance between stimulant users and comparison subjects. Mann-Whitney tests were applied for subsequent pairwise comparisons.
The underlying idea of our analysis approach was, first, to identify differences in CVLT-II performance between stimulant users and comparison subjects, acknowledging one of the most striking potentially conflicting factors: marijuana use. The number of lifetime THC uses, as assessed with the Semi Structured Assessment for the Genetics of Alcoholism and Timeline FollowBack methods, differed between stimulant users and comparison subjects (p Ͻ .001, Table 1 ). In stimulant users, THC use preceded stimulant use by 2.61 Ϯ 2.01 years, and lifetime stimulant use was correlated with lifetime marijuana co-use (r ϭ .281, p Ͻ .001). To account for a potential effect of lifetime THC use on verbal memory performance, we divided stimulant users into below and above median THC users on the basis of their lifetime marijuana use (ln (1ϩlifetime marijuana uses) , lnTHC). Seventyseven stimulant users (Below Median THC Stimulant Users) reported a lifetime marijuana use below the stimulant users' median of 5.897 (lnTHC) and were compared with 77 stimulant users classified as Above Median THC Stimulant Users and 48 comparison subjects (Table 1) .
Second, we examined the effect of cumulative stimulant use on verbal learning and memory performance by directly comparing stimulant users with low and high lifetime stimulant use. Users were divided according to their declared lifetime use of stimulants into Below (n ϭ 77) and Above Median (n ϭ 77) Stimulant Users (ln (1ϩlifetime stimulant uses) , [lnSTIM], median 3.239). Correlation analyses were performed between lnSTIM and those verbal learning and memory measures differing between stimulant users and comparison subjects.
Third, the effect of preferred stimulant type on CVLT-II performance was examined. One hundred eleven stimulant users had consumed any type of prescription stimulant (methylphenidate and/or prescription amphetamines) at least once. Four www.sobp.org/journal subjects had used methylphenidate only, and 67 had used prescription amphetamines only. Stimulant users were split into pure prescription stimulant users (n ϭ 35), pure cocaine users (n ϭ 13), and users with no preference for a stimulant type (n ϭ 56). Due to the limited number of subjects describing the use of cocaine only, we also grouped stimulant users into users with a dominant use of prescription stimulants (Ն 80% of total stimulant use of prescription amphetamines and/or methylphenidate, n ϭ 55) or cocaine (Ն80% cocaine, n ϭ 43). Subgroups were compared with comparison subjects, and correlation analyses with lifetime stimulant use and CVLT-II performance were run for subgroups.
Results
One hundred fifty-four stimulant users (93 men) and 48 healthy comparison subjects ( Tables 2 and 3) . Among stimulant users, the frequency of marijuana use did not affect CVLT-II performance as indicated by the fact that below and above median marijuana users did not differ on any of the verbal learning and memory measures (p values Ͼ .32). Stimulant users with below and those with above median marijuana use both performed significantly worse than comparison subjects on the CVLT-II as measured by most of the immediate and all delayed recall variables (Table 2 ). Both subgroups of stimulant users produced more intrusion errors than comparison subjects-analyses that reached statistical significance for delayed and cued recall intrusions ( Figure 1, Table 3 ). Stimulant users also showed deficits on recall and recognition discriminability measures relative to stimulant-naive comparison subjects (Table 3) . Stimulant users with below (n ϭ 77) and above (n ϭ 77) median marijuana (THC) use. Post hoc Mann-Whitney tests revealed that stimulant users with relatively lower and higher THC co-use do not differ in performance. Instead, significant group differences are due to stimulant users performing worse than comparison subjects. Effect sizes were calculated applying partial 2 . 
Effect of Lifetime Stimulant Use.
To evaluate whether cumulative use affects performance in early stages of stimulant use, we first examined whether those CVLT-II measures identified in the aforementioned analyses as differing between users and comparison subjects showed a significant correlation with lifetime stimulant use (correlations with lnSTIM in stimulant users). None of these correlations were significant (p values Ͼ .146) (i.e., cumulative stimulant use was not associated with CVLT-II performance of the combined group of users of cocaine and prescription stimulants).
As an alternative categorical approach, stimulant users were subdivided according to their cumulative lifetime stimulant use into users with below and above median stimulant uses. Performance of these subgroups and comparison subjects was compared with t tests as assumptions for parametric analyses were fulfilled. Stimulant users with low and high lifetime uses did not differ on any of these CVLT-II measures (p values Ͼ .35), further underlining that cumulative use of stimulants was not related to verbal learning and memory performance in early stages of stimulant use. Correlations of verbal measures and lifetime stimulant use in both subgroups separately were not significant. Thus, individuals with relatively greater lifetime exposure to stimulants did not show worse performance on measures of learning and memory.
Effect of Preferred Stimulant Type. Unlike other stimulant users, individuals who reported exclusive use of cocaine did not differ from comparison subjects on all but one measure (Cued Recall Intrusions, p ϭ .049, Table 4 ). However, given the relatively smaller sample (n ϭ 13 for pure cocaine users vs. n ϭ 48 for comparison subjects), caution is needed when interpreting these results. Respective effect sizes (Cohen's d) were medium to high (Table 4) , supporting the relevance of our findings. The other subgroups (pure prescription users, dominant prescription users, dominant cocaine users, user with no preference for either stimulant type) in most parts showed the same deficits compared to stimulant-naive subjects, which had been revealed for the entire group of stimulant users (Table 4 ; Supplement 1).
To examine the relationship between the number of lifetime uses of different types of stimulants, we performed correlation analyses with CVLT-II performance in subgroups of stimulant users preferring cocaine or prescription stimulants or stating no preference for either stimulant type. There were no significant correlations between the amount of specific type of stimulants consumed and CVLT-II performance in pure or dominant cocaine stimulant users, dominant prescription stimulant users, and users with no preference.
However, for the subgroup of users consuming prescription amphetamines and/or methylphenidate only, correlation analyses revealed that greater lifetime exposure to prescription stimulants was associated with poorer verbal recall performance (Trial 5: r ϭ Ϫ.458, p ϭ .006; Total Trial 1-5: r ϭ Ϫ.357, p ϭ .036; Short-Delay Free Recall: r ϭ Ϫ.382, p ϭ .024; Short-Delay Cued Recall: r ϭ Ϫ.404, p ϭ .016; Long-Delay Cued Recall: r ϭ Ϫ.405, p ϭ .016; Figure 2 ). Thus, despite the self-reported incentive to use prescription stimulants to improve cognitive performance, greater lifetime 
Discussion
This study aimed to determine whether subtle learning and memory problems characterize individuals who exhibit occasional but not chronic use of stimulants. Our study yielded two main results. First, stimulant users showed significantly worse performance on a task requiring the recall of verbal material. Recall capacities were impaired on immediate and delayed trials and even when cues were provided. Second, we identified characteristic patterns of learning and memory performance in users preferring a certain type of psychostimulant. Specifically, increasing use of prescription stimulants but not cocaine was associated with stronger recall deficits. Thus, these results indicate that even individuals who used stimulants minimally nevertheless showed learning and memory problems, which is consistent with the idea that these problems preceded the initiation of drug use. On the other hand continued use of these drugs in general and of prescriptiontype stimulants in particular contributes to further exaggeration of learning and memory problems.
Stimulant users generated, besides significant verbal recall deficits, more intrusion errors than comparison subjects. These findings reflect, along with an increased rate of false positives, which has recently been described in chronic cocaine users (7), a tendency in occasional users to confabulate. We also found that occasional users, similar to cocaine dependent subjects (7, 10) , exhibited a diminished ability to distinguish target words from distractors during recognition testing. This recognition deficit was accompanied by a deficiency in rejecting semantically related distractors. Interestingly, a similar pattern of learning and memory deficiencies has previously been described in chronic cocaine users (6, 7, 10, 15) , whereas little had been known about the neurocognitive profile of individuals who misuse prescription stimulants infrequently. The fact that learning and memory weaknesses were identified in individuals with very limited exposure to stimulants suggests that these deficits preceded stimulant use. Moreover, the experience of these problems in academic environments, which demand a high level of cognitive performance, might have contributed to the incentive to use drugs that are perceived to enhance performance. Alternatively, recall and memory deficits could have been a consequence of stimulant use. However, this possibility would be more plausible if there was a dose-relationship to the observed dysfunctions (i.e., if individuals with greater numbers of stimulant use exhibited stronger problems). In contrast, in the combined group of occasional cocaine and prescription stimulant users, cumulative stimulant use was not associated with performance, and deficiencies were found to be on similar levels in high-and low-amount users. That no effect of age or the amount of lifetime use on CVLT-II performance could be detected in this sample homogeneous in age further supports the notion of a pre-existing neurocog- Increased Impulsivity? unpublished data; 2010) that might have led to stimulant initiation and clearly invite the hypothesis that deficits in learning and memory are a trait characteristic that precedes stimulant use. We cannot entirely rule out that the limited variability in age and amount or duration of use might have covered dose-performance relationships, although this is unlikely, given the aforementioned results.
In contrast to our results of the combined group of users of cocaine and prescription stimulants, those users with a lifetime use of cocaine only did not differ from comparison subjects. Although these results have to be replicated because they rely on a small subsample, we found clear evidence for an association of impaired recall capacities with cumulative use in users consuming prescription stimulants only. It is important to point out that, despite the self-reported use of prescription stimulants to improve performance on tests and examinations, we observed a negative impact of cumulative use of these medications on verbal recall performance. Given the cross-sectional study design, we cannot rule out the possibility that originally more severely impaired subjects consumed more prescription stimulants to boost deficient performance. In pure prescription stimulant users, reading skills, which have been found to remain relatively unaffected by brain changes, did not differ from comparison subjects and were not associated with cumulative use. It thus seems unlikely that initially more severely impaired subjects consumed more prescription stimulants but rather that prescription stimulants increasingly impair verbal recall skills.
It is important to point out that verbal learning and memory deficits were not due to the frequent co-use of marijuana, which is common in this population. Moreover, CVLT-II inherent measures (Trials 1 and B) point at comparable attention or working memory capacities in users and comparison subjects, a hypothesis that would need to be supported by specific assessments. One limiting factor of our study is that the design was not completely prospective. Our cross-sectional data cannot directly account for pre-existing neurocognitive characteristics. We addressed this methodological challenge by investigating stimulant users with only minimal use and comparing users with relatively low and high lifetime uses and, lastly, by correlation analyses with cumulative stimulant use.
Conclusions
Individuals who have used prescription stimulants and cocaine rarely show significant deficits in verbal recall, learning, and memory. These deficits resemble those of chronic users and are most pronounced in recall domains. There is some evidence for differential effects of cocaine and prescription stimulants. Surprisingly, cumulative use of prescription stimulants rather than cocaine was associated with stronger verbal recall deficits. Taken together, our results support the idea that pre-existing verbal learning and memory deficiencies might lead individuals to seek means to attenuate these deficits by using stimulants. Although short-term effects of stimulants may be beneficial, cumulative use, particularly of prescription amphetamines and methylphenidate, may ultimately intensify learning and memory problems.
